Dual Specificity Protein Kinase (CLK) as A Drug Target and Biomarker for Various Diseases

Target Name: Dual specificity protein kinase (CLK)

NCBI ID: P39644

Dual specificity protein kinase (CLK)

Other Name(s): Dual specificity protein kinase | CDC-like kinase | CLK

Dual Specificity Protein Kinase (CLK) as A Drug Target and Biomarker for Various Diseases

Dual specificity protein kinase (CLK) is a protein that plays a crucial role in cell signaling pathways. It is a non-species specific protein that is involved in the regulation of various cellular processes such as cell growth, differentiation, and apoptosis. CLK is a protein that is expressed in most tissues and cells of the human body. It is a key regulator of the G1/S transition, which is the critical step in the cell cycle where the cell prepares for cell division.

CLK is a protein that can function as a kinase or a phosphatidylinositol (PI) binding protein. As a kinase, CLK catalyzes the conversion of ATP to ADP and Pi, which is the energy currency of the cell. As a PI binding protein, CLK can interact with the PI-phospholipase C (PLC) and regulate its activity.

Dual specificity protein kinase (CLK) has been identified as a potential drug target and a biomarker for various diseases. CLK has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. It is a key regulator of the G1/S transition, which is the critical step in the cell cycle where the cell prepares for cell division.

CLK has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. CLK has been shown to play a role in the regulation of vascular permeability and blood vessel formation, which is critical for the proper functioning of the circulatory system.

CLK has also been shown to be involved in the regulation of cell adhesion. CLK can interact with the cadherin protein, which is a transmembrane protein that plays a critical role in cell-cell adhesion. CLK can regulate the activity of the cadherin protein, which is involved in the regulation of cell-cell adhesion.

CLK has also been shown to be involved in the regulation of cell survival. CLK can interact with the B-cell lymphoma 1 (BL1) gene, which is a critical regulator of cell survival. CLK can regulate the activity of the BL1 gene, which is involved in the regulation of cell survival.

Drugs that target CLK have been shown to be effective in treating various diseases. For example, inhibitors of CLK have been shown to be effective in treating breast cancer. These inhibitors can inhibit the activity of CLK and reduce the number of cell divisions that occur in cancer cells.

In addition to its role in cancer treatment, CLK has also been shown to be a potential biomarker for various diseases. For example, CLK has been shown to be involved in the regulation of the development and progression of neurodegenerative diseases. CLK can interact with the neurotransmitter dopamine, which is involved in the regulation of mood and motivation.

In addition to its role in neurodegenerative diseases, CLK has also been shown to be involved in the regulation of various physiological processes that are critical for human health. For example, CLK is involved in the regulation of blood pressure, which is critical for maintaining blood flow to the body's various tissues.

Conclusion

In conclusion, Dual specificity protein kinase (CLK) is a non-species specific protein that plays a crucial role in cell signaling pathways. It is involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. CLK is a key regulator of the G1/S transition and can function as a kinase or a PI binding protein.

CLK has been identified as a potential drug target and a biomarker for various diseases. CLK has been shown to be involved in the regulation of cell adhesion, cell survival, and blood pressure. inhibitors of CLK have been shown to be effective in treating various diseases, including breast cancer and

Protein Name: Dual Specificity Protein Kinase (CLK) (nonspecified Subtype)

The "Dual specificity protein kinase (CLK) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Dual specificity protein kinase (CLK) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets